Shan-Hua ChungPrincipal Scientist and Matrix Lead in Cell Technologies at RocheSpeaker
Profile
Shan-Hua Chung joined Roche's Cell Technologies department in 2015 as a post-doctoral researcher and has advanced to Principal Scientist. She has significantly contributed to host cell line engineering, cell line development process troubleshooting, and optimization. Shan-Hua has also been instrumental in implementing in-silico cell line development processes. Additionally, she plays a key role in drug development, successfully leading projects from early R&D phases through to Phase 1 clinical studies.
Agenda Sessions
Advances in Machine Learning for Cell Line Development To Predict Better Clones, Reduce Timelines & Experiments
, 09:05View Session